Contingency Management for Smoking Cessation in Adolescent Smokers - Phase IV, Enhancing a High School Based Smoking Cessation Program
Overview
- Phase
- Not Applicable
- Intervention
- Cognitive Behavioural Therapy
- Conditions
- Nicotine Dependence
- Sponsor
- Yale University
- Enrollment
- 154
- Locations
- 1
- Primary Endpoint
- Abstinence Rates at the End of Treatment
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to examine the the efficacy of adjunctive nicotine replacement therapy when used in combination with the contingency management (CM) + cognitive behavioral therapy intervention. Subjects will be randomly assigned to receive either a nicotine transdermal patch or a placebo patch as well as being randomly assigned to receive either CM or no CM; all subjects will receive cognitive behavioral therapy. We hypothesize that that subjects receiving both active nicotine patch and CM will have higher rates of abstinence from tobacco than subjects in the other groups.
Investigators
Eligibility Criteria
Inclusion Criteria
- •High School aged
- •Desire to quit smoking
- •Smoking \>5 cigarettes per day
- •Able to read and write in English
Exclusion Criteria
- •Current dependence on other substances
- •Medical conditions that would contraindicate the use of a nicotine patch
Arms & Interventions
Active Nicotine Patch and Contingency Management
Subjects in this group will receive Contingency Management and active nicotine patch
Intervention: Cognitive Behavioural Therapy
Active Nicotine Patch and Contingency Management
Subjects in this group will receive Contingency Management and active nicotine patch
Intervention: Contingency Management
Active Nicotine Patch and Contingency Management
Subjects in this group will receive Contingency Management and active nicotine patch
Intervention: Nicotine Transdermal Patch
Nicotine Patch with no Contingency Management
Subjects in this group will receive active nicotine patch without contingency management for abstinence
Intervention: Cognitive Behavioural Therapy
Nicotine Patch with no Contingency Management
Subjects in this group will receive active nicotine patch without contingency management for abstinence
Intervention: Nicotine Transdermal Patch
Placebo patch and Contingency Management
Subjects in this group will receive a placebo transdermal patch and contingency management
Intervention: Cognitive Behavioural Therapy
Placebo patch and Contingency Management
Subjects in this group will receive a placebo transdermal patch and contingency management
Intervention: Contingency Management
Placebo Patch and no Contingency Management
Subjects in this group will receive a placebo patch and will not receive contingency management
Intervention: Cognitive Behavioural Therapy
Outcomes
Primary Outcomes
Abstinence Rates at the End of Treatment
Time Frame: 6 weeks
Our primary outcome will be point prevalence abstinence at the end of the treatment period defined as any self-report of cigarette use during the seven days prior to the last appointment confirmed by urine analysis.
Secondary Outcomes
- Continuous Abstinence During Treatment(6 weeks)